Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3422]
News [7838]
Articles [63]
Editorials [9]
Conferences [210]
elearning [49]
Lenalidomide with melphalan + prednisone and lenalidomide maintenance for...
Prof Antonio Palumbo - University of Torino, Italy
Lenalidomide with melphalan + prednisone and lenalidomide maintenance for multiple myeloma ( Prof Antonio Palumbo - University of Torino, Italy )
13 Dec 2011
Evolving treatment options in castration-resistant prostate cancer
Prof Kurt Miller, Dr Eleni Efstathiou, Dr Karim Fizazi and Dr Göran Ahlgren
Evolving treatment options in castration-resistant prostate cancer ( Prof Kurt Miller, Dr Eleni Efstathiou, Dr Karim Fizazi and Dr Göran Ahlgren )
6 Dec 2011
Advances in the treatment of T-cell lymphoma
Prof John Gribben, Dr Myron Czuczman, Dr Randy Gascoyne, Prof Michael...
Advances in the treatment of T-cell lymphoma ( Prof John Gribben, Dr Myron Czuczman, Dr Randy Gascoyne, Prof Michael Pfreundschuh and Prof Wyndham Wilson )
6 Dec 2011
Key research from the 9th International Workshop for Lymphoma
Professor John Gribben, Dr Myron Czuczman, Dr Randy Gascoyne, Professor Michael...
Key research from the 9th International Workshop for Lymphoma ( Professor John Gribben, Dr Myron Czuczman, Dr Randy Gascoyne, Professor Michael Pfreundschuh and Prof Wyndham Wilson )
6 Dec 2011
The role of genomic testing in personalised medicine for breast cancer
Professor David Miles, Mount Vernon Hospital, London, UK
The role of genomic testing in personalised medicine for breast cancer ( Professor David Miles, Mount Vernon Hospital, London, UK )
6 Dec 2011
Active angiogenesis drugs in development
Prof Bradley Monk – University of California Irvine, USA
Active angiogenesis drugs in development ( Prof Bradley Monk – University of California Irvine, USA )
24 Nov 2011
Intraperitoneal therapy: current questions
Prof Franco Muggia – New York University Medical Center, USA
Intraperitoneal therapy: current questions ( Prof Franco Muggia – New York University Medical Center, USA )
24 Nov 2011
Use of modified T-cells to treat advanced CLL
Prof David Porter - University of Pennsylvania, Philadelphia, USA
Use of modified T-cells to treat advanced CLL ( Prof David Porter - University of Pennsylvania, Philadelphia, USA )
24 Nov 2011
PARP inhibitory treatment for BRCA mutated and sporadic triple negative breast...
Dr Daniel Silver - Dana Farber Cancer Institute, Boston, Massachusetts, USA
PARP inhibitory treatment for BRCA mutated and sporadic triple negative breast cancer ( Dr Daniel Silver - Dana Farber Cancer Institute, Boston, Massachusetts, USA )
24 Nov 2011
Chemotherapy Foundation Symposium 2011
Prof Edward Ambinder - The Mount Sinai Hospital, New York, USA
Chemotherapy Foundation Symposium 2011 ( Prof Edward Ambinder - The Mount Sinai Hospital, New York, USA )
24 Nov 2011
New trastuzumab combinations for HER2 positive breast cancer
Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium
New trastuzumab combinations for HER2 positive breast cancer ( Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
24 Nov 2011
Pomegranate extract for prostate cancer patients
Prof Michael Carducci - Johns Hopkins Medical Institutions, Baltimore, USA
Pomegranate extract for prostate cancer patients ( Prof Michael Carducci - Johns Hopkins Medical Institutions, Baltimore, USA )
24 Nov 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation